Authors:
Patriotis, C
Russeva, MG
Lin, JH
Srinivasula, SM
Markova, DZ
Tsatsanis, C
Makris, A
Alnemri, ES
Tsichlis, PN
Citation: C. Patriotis et al., Tpl-2 induces apoptosis by promoting the assembly of protein complexes that contain caspase-9, the adapter protein Tvl-1, and procaspase-3, J CELL PHYS, 187(2), 2001, pp. 176-187
Authors:
Chang, J
Powles, TJ
Allred, DC
Ashley, SE
Makris, A
Gregory, RK
Osborne, CK
Dowsett, M
Citation: J. Chang et al., Prediction of clinical outcome from primary tamosifen by expression of biologic markers in breast cancer patients, CLIN CANC R, 6(2), 2000, pp. 616-621
Authors:
Chang, J
Powles, TJ
Allred, DC
Ashey, SE
Clark, GM
Makris, A
Assersohn, L
Gregory, RK
Osborne, CK
Dowsett, M
Citation: J. Chang et al., Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer, J CL ONCOL, 17(10), 1999, pp. 3058-3063
Authors:
Makris, A
Powles, TJ
Allred, DC
Ashley, SE
Trott, PA
Ormerod, MG
Titley, JC
Dowsett, M
Citation: A. Makris et al., Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: A pilot study, BREAST CANC, 53(1), 1999, pp. 51-59
Authors:
Lin, JH
Makris, A
McMahon, C
Bear, SE
Patriotis, C
Prasad, VR
Brent, R
Golemis, EA
Tsichlis, PN
Citation: Jh. Lin et al., The ankyrin repeat-containing adaptor protein Tvl-1 is a novel substrate and regulator of Raf-1, J BIOL CHEM, 274(21), 1999, pp. 14706-14715
Authors:
Makris, A
Powles, TJ
Kakolyris, S
Dowsett, M
Ashley, SE
Harris, AL
Citation: A. Makris et al., Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinoma, CANCER, 85(9), 1999, pp. 1996-2000
Authors:
Makris, A
Powles, TJ
Ashley, SE
Chang, J
Hickish, T
Tidy, VA
Nash, AG
Ford, HT
Citation: A. Makris et al., A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer, ANN ONCOL, 9(11), 1998, pp. 1179-1184